MILESTONE PHARMACEUTICALS
Milestone Pharmaceuticals is a drug development company developing novel small molecule therapeutics based on clinically validated mechanisms for cardiovascular diseases. Milestone's lead product is a novel and potent short-acting calcium channel antagonist for the systemic treatment of transient cardiovascular conditions such as atrial arrhythmias and angina.
MILESTONE PHARMACEUTICALS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2005-01-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Website Url:
http://www.milestonepharma.com
Total Employee:
11+
Status:
Active
Contact:
(514) 336-0444
Total Funding:
167.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Advanced Proteome Therapeutics
Advanced Proteome Therapeutics is focused on the development of novel therapeutics for the treatment of cancerous tumors.
Aerpio Pharmaceuticals
Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Alios BioPharma
Alios BioPharma is a biotechnology company developing novel medicines for the treatment of viral diseases.
Allinaire Therapeutics
Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases.
Amplo Biotechnology
Amplo Biotechnology is to develop multiple, potentially curative, Adeno-Associated Viral (AAV) therapies for the neuromuscular junction.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arisaph Pharmaceuticals
Arisaph Pharmaceuticals is focused on the development of therapies for cancer, cardiovascular disease, and diabetes.
BIOMx
BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.
Callidus Biopharma
Callidus Biopharma is a drug discovery company developing enzyme replacement therapies for lysosomal storage disorders.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
CTI BioPharma
CTI BioPharma is a biopharmaceutical company developing oncology products for the treatment of cancer.
Cerulean Pharma
Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
Chronos Therapeutics
Chronos Therapeutics is a drug development company focused on the development of drugs for the treatment of age-related diseases.
Conatus Pharmaceuticals
Conatus Pharmaceuticals is focused on the development of human therapeutics to treat liver failures and cancer.
Elstar Therapeutics
Fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating multi-functional therapeutics.
Enosi Life Sciences
Enosi Life Sciences is a drug research and development company providing therapeutics for autoimmune diseases and cancer.
Foresight Biotherapeutics
Foresight Biotherapeutics is a drug development company developing therapies to address unmet needs in ophthalmology and otolaryngology.
Furiex Pharmaceuticals
Furiex Pharmaceuticals is a drug development collaboration company focused on improving the value of partnered drug programs.
Gene Sciences, Inc.
Gene Sciences Inc. is developing novel DNA targeted therapeutics for the treatment of human genetic diseases.
Inari Medical
Inari Medical is a medical device company that develops devices for the interventional treatment of cardiovascular diseases.
Inspire Medical Systems
Inspire Medical Systems develops implantable therapeutic devices for the treatment of obstructive sleep apnea.
Jecure Therapeutics
Jecure Therapeutics is focused on the discovery of innovative therapeutics for the treatment of non-alcoholic steatohepatitis.
KinaRx
KinaRx is a biotech firm focuses on the development of novel kinase inhibitors for the treatment of Acute myeloid leukemia.
NovelMed Therapeutics
NovelMed Therapeutics is a biotechnology company developing novel therapies for orphan and non-orphan diseases.
Novita Pharmaceuticals
Novita Pharmaceuticals is a developer of therapeutic drugs for the treatment of cancer.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Sierra Oncology
Sierra Oncology is a clinical-stage drug development company that advances targeted therapeutics for the treatment of cancer patients.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Reven Pharmaceuticals
Reven Pharmaceuticals is a clinical-stage company providing solutions for the treatment of vascular and metabolic-related conditions.
Motus Therapeutics
Motus Therapeutics is a biotechnology company developing peptide therapeutics for the treatment of metabolic diseases.
Theron Pharmaceuticals
Theron Pharmaceuticals is a biotechnology company that develops therapeutic products for the treatment of chronic respiratory diseases.
TVAX Biomedical
TVAX Biomedical develops cell-based immunotherapy for the treatment of cancer.
Vaccinogen
Vaccinogen manufactures vaccines and other immunotherapeutic products for cancers and infectious diseases.
VentiRx Pharmaceuticals
VentiRx Pharmaceuticals develops novel TLR8 therapeutics for the treatment of cancer, allergy, and respiratory and autoimmune diseases.
Versartis
Versartis is a biotechnology company developing therapeutic proteins for the treatment of endocrine disorders.
Vigeo Therapeutics
Vigeo Therapeutics is a biopharmaceutical company developing novel therapeutic agents intended to treat advanced malignant tumors.
Current Advisors List
Board_observer
Board_observer
Board_member
2020-09-01
Board_member
Board_member
Current Employees Featured
Joseph G. Oliveto President & Chief Executive Officer @ Milestone Pharmaceuticals
President & Chief Executive Officer
Amit Hasija Chief Financial Officer and Executive Vice President of Corporate Development @ Milestone Pharmaceuticals
Chief Financial Officer and Executive Vice President of Corporate Development
2019-09-01
Eric W. Linsley Director @ Milestone Pharmaceuticals
Director
Lorenz Muller Chief Commercial Officer @ Milestone Pharmaceuticals
Chief Commercial Officer
Francis Pla Chief Medical Officer @ Milestone Pharmaceuticals
Chief Medical Officer
Jeff Nelson Chief Operating Officer @ Milestone Pharmaceuticals
Chief Operating Officer
Founder
Stock Details
Investors List
Amplitude Venture Capital
Amplitude Venture Capital investment in Post-IPO Equity - Milestone Pharmaceuticals
Novo Holdings
Novo Holdings investment in Series D - Milestone Pharmaceuticals
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Series D - Milestone Pharmaceuticals
Pappas Capital
Pappas Capital investment in Series D - Milestone Pharmaceuticals
Tekla Capital Management
Tekla Capital Management investment in Series D - Milestone Pharmaceuticals
BDC Capital Corporation
BDC Capital Corporation investment in Series D - Milestone Pharmaceuticals
Forbion Capital Partners
Forbion Capital Partners investment in Series D - Milestone Pharmaceuticals
Boxer Capital
Boxer Capital investment in Series D - Milestone Pharmaceuticals
Domain Associates
Domain Associates investment in Series D - Milestone Pharmaceuticals
GO CAPITAL
GO CAPITAL investment in Series D - Milestone Pharmaceuticals
Official Site Inspections
http://www.milestonepharma.com Semrush global rank: 3.84 M Semrush visits lastest month: 3.44 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Milestone Pharmaceuticals"
Milestone Pharmaceuticals: With You Every …
We are developing our investigational product etripamil, a novel, non-dihydropyridine calcium channel blocker delivered as a …See details»
About Us - Milestone Pharmaceuticals
We are a patient-centric, clinical-stage biopharmaceutical company dedicated to bringing etripamil to patients living with paroxysmal supraventricular …See details»
Our Leadership Team - About Us - Milestone Pharma
Our executive team has extensive experience and major successes at both major pharmaceutical and emerging life sciences companies.See details»
Investor Overview | Milestone Pharmaceuticals, Inc.
Investor Overview | Milestone Pharmaceuticals, Inc.See details»
Milestone Pharmaceuticals - Crunchbase Company …
Contact Email info@milestonepharma.com Phone Number (514) 336-0444 Milestone Pharmaceuticals is a drug development company developing novel …See details»
Milestone Pharmaceuticals, Inc. | LinkedIn
Milestone Pharmaceuticals, Inc. | 10,104 followers on LinkedIn. Headquartered in Montreal, with a growing subsidiary in Charlotte, NC | Thank you for your interest in Milestone …See details»
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year …
Dec 31, 2024 Kim Fox, Vice President, Communications, kfox@milestonepharma.com . Investor Relations Kevin Gardner, kgardner@lifesciadvisors.com : Milestone Pharmaceuticals Inc. …See details»
Milestone Pharmaceuticals, Inc. (Milestone Pharmaceuticals, Inc.)
Contact: Kim Fox, Vice President, Communications, kfox@milestonepharma.com Investor Relations Chris Calabrese, ccalabrese@lifesciadvisors.com Kevin Gardner, …See details»
Milestone Pharmaceuticals Inc. (MIST) - Yahoo Finance Canada
See the company profile for Milestone Pharmaceuticals Inc. (MIST) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Joseph Oliveto: Board of Directors - Milestone Pharma
Prior to Pappas Ventures, Mr. Oliveto served in a number of progressively senior positions across several operating areas over an 18-year career at Hoffmann-La Roche Inc., including as a …See details»
Milestone Pharmaceuticals Announces FDA Acceptance of New …
May 29, 2024 MONTREAL and CHARLOTTE, N.C., May 29, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on …See details»
Milestone Pharmaceuticals, Inc. | LinkedIn
Milestone Pharmaceuticals, Inc. Biotechnology Research Montreal, QC 11,057 followers Headquartered in Montreal, with a growing subsidiary in Charlotte, NCSee details»
Milestone Pharmaceuticals, Inc. - SignalHire
Phone Number: 1-877-207-4764: Milestone Pharmaceut... industries Biotech, Pharmaceuticals: Headquarters LocationSee details»
Milestone Pharmaceuticals - Overview, News & Similar ... - ZoomInfo
Aug 13, 2024 Milestone Pharmaceuticals contact info: Phone number: (514) 336-0444 Website: www.milestonepharma.com What does Milestone Pharmaceuticals do? Milestone …See details»
Milestone Pharma: Overview and Outlook – Medicine to Market
Mar 3, 2025 Milestone Pharmaceuticals is transforming cardiac care with its innovative CARDAMYST™ (etripamil) nasal spray, designed for fast, patient-administered treatment of …See details»
Board of Directors - About Us - Milestone Pharma
Our Board of Directors is composed of accomplished industry leaders with extensive experience in healthcare, pharmaceuticals, corporate and business development, and finance who are …See details»
Press Releases - investors.milestonepharma.com
Sep 22, 2020 MONTREAL and CHARLOTTE, N.C., Sept. 22, 2020 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the …See details»
Milestone Pharmaceuticals - Craft
Oct 29, 2024 Montréal, Québec HQ. Canada. 420 1111 Boulevard Dr.-Frederik-Philips. Charlotte, NC. United States. 7422 Carmel Executive Park Dr #300See details»
Contact Us - Milestone Pharma
If you have a medical emergency, please call 911. If you are experiencing symptoms of PSVT, please call your Healthcare Provider or call 911. For questions regarding Milestone or …See details»
Milestone Pharmaceuticals to Present Clinical Data on
Mar 20, 2025 MONTREAL and CHARLOTTE, N.C., March 20, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) a biopharmaceutical company focused on...See details»